Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (741-750 of 903) with videos related to

Pageof 91
Sort By:
Journal of Alzheimer'S Disease : JAD|October 18, 2017
Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort StudyBabette L R Reijs, Stephanie J B Vos, Hilkka Soininen, et al.
Neuroimage. Clinical|April 25, 2021
Differential patterns of gray matter volumes and associated gene expression profiles in cognitively-defined Alzheimer's disease subgroupsColin Groot, Michel J Grothe, Shubhabrata Mukherjee, et al.
JAMA Neurology|June 30, 2025
Amyloid-Beta Pathology and Cognitive Performance in CentenariansSusan K Rohde, Maruelle C Luimes, Linda M C Lorenz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's diseaseClifford R Jack, Frederik Barkhof, Matt A Bernstein, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 1, 2020
cCOG: A web-based cognitive test tool for detecting neurodegenerative disordersHanneke F M Rhodius-Meester, Teemu Paajanen, Juha Koikkalainen, et al.
Human Brain Mapping|December 15, 2012
Amyloid and its association with default network integrity in Alzheimer's diseaseSofie M Adriaanse, Ernesto J Sanz-Arigita, Maja A A Binnewijzend, et al.
Neurology|August 15, 2022
A Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET ImagingJulien Dumurgier, Séverine Sabia, Henrik Zetterberg, et al.
Journal of Alzheimer'S Disease : JAD|May 24, 2021
Clinical Phenotypes of Behavioral Variant Frontotemporal Dementia by Age at OnsetJay L P Fieldhouse, Flora T Gossink, Thomas C Feenstra, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 19, 2020
The influence of diversity on the measurement of functional impairment: An international validation of the Amsterdam IADL Questionnaire in eight countriesMark A Dubbelman, Merike Verrijp, David Facal, et al.
Scientific Reports|May 20, 2020
CDH6 and HAGH protein levels in plasma associate with Alzheimer's disease in APOE ε4 carriersShahzad Ahmad, Marta Del Campo Milan, Oskar Hansson, et al.
Pageof 91

Showing results (741-750 of 903) with videos related to

Sort By:
Pageof 91
Journal of Alzheimer'S Disease : JAD|October 18, 2017
Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort StudyBabette L R Reijs, Stephanie J B Vos, Hilkka Soininen, et al.
Neuroimage. Clinical|April 25, 2021
Differential patterns of gray matter volumes and associated gene expression profiles in cognitively-defined Alzheimer's disease subgroupsColin Groot, Michel J Grothe, Shubhabrata Mukherjee, et al.
JAMA Neurology|June 30, 2025
Amyloid-Beta Pathology and Cognitive Performance in CentenariansSusan K Rohde, Maruelle C Luimes, Linda M C Lorenz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's diseaseClifford R Jack, Frederik Barkhof, Matt A Bernstein, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 1, 2020
cCOG: A web-based cognitive test tool for detecting neurodegenerative disordersHanneke F M Rhodius-Meester, Teemu Paajanen, Juha Koikkalainen, et al.
Human Brain Mapping|December 15, 2012
Amyloid and its association with default network integrity in Alzheimer's diseaseSofie M Adriaanse, Ernesto J Sanz-Arigita, Maja A A Binnewijzend, et al.
Neurology|August 15, 2022
A Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET ImagingJulien Dumurgier, Séverine Sabia, Henrik Zetterberg, et al.
Journal of Alzheimer'S Disease : JAD|May 24, 2021
Clinical Phenotypes of Behavioral Variant Frontotemporal Dementia by Age at OnsetJay L P Fieldhouse, Flora T Gossink, Thomas C Feenstra, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 19, 2020
The influence of diversity on the measurement of functional impairment: An international validation of the Amsterdam IADL Questionnaire in eight countriesMark A Dubbelman, Merike Verrijp, David Facal, et al.
Scientific Reports|May 20, 2020
CDH6 and HAGH protein levels in plasma associate with Alzheimer's disease in APOE ε4 carriersShahzad Ahmad, Marta Del Campo Milan, Oskar Hansson, et al.
Pageof 91